ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PARP Inhibitor Biomarkers Testing Product Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-10M7912
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PARP Inhibitor Biomarkers Testing Product Market Insights and Forecast to 2028
BUY CHAPTERS

Global PARP Inhibitor Biomarkers Testing Product Market Research Report 2025

Code: QYRE-Auto-10M7912
Report
September 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Myriad Genetics Inc
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories Inc.
BPS Bioscience, Inc.

PARP Inhibitor Biomarkers Testing Product Market

The global market for PARP Inhibitor Biomarkers Testing Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for PARP Inhibitor Biomarkers Testing Product is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PARP Inhibitor Biomarkers Testing Product is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of PARP Inhibitor Biomarkers Testing Product include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Testing Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Testing Product.
The PARP Inhibitor Biomarkers Testing Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PARP Inhibitor Biomarkers Testing Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP Inhibitor Biomarkers Testing Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PARP Inhibitor Biomarkers Testing Product Market Report

Report Metric Details
Report Name PARP Inhibitor Biomarkers Testing Product Market
Segment by Type
  • Testing Kits
  • Testing Assays
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PARP Inhibitor Biomarkers Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PARP Inhibitor Biomarkers Testing Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the PARP Inhibitor Biomarkers Testing Product Market report?

Ans: The main players in the PARP Inhibitor Biomarkers Testing Product Market are Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc.

What are the Application segmentation covered in the PARP Inhibitor Biomarkers Testing Product Market report?

Ans: The Applications covered in the PARP Inhibitor Biomarkers Testing Product Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the PARP Inhibitor Biomarkers Testing Product Market report?

Ans: The Types covered in the PARP Inhibitor Biomarkers Testing Product Market report are Testing Kits, Testing Assays

1 PARP Inhibitor Biomarkers Testing Product Market Overview
1.1 Product Definition
1.2 PARP Inhibitor Biomarkers Testing Product by Type
1.2.1 Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Testing Kits
1.2.3 Testing Assays
1.3 PARP Inhibitor Biomarkers Testing Product by Application
1.3.1 Global PARP Inhibitor Biomarkers Testing Product Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global PARP Inhibitor Biomarkers Testing Product Market Size Estimates and Forecasts
1.4.1 Global PARP Inhibitor Biomarkers Testing Product Revenue 2020-2031
1.4.2 Global PARP Inhibitor Biomarkers Testing Product Sales 2020-2031
1.4.3 Global PARP Inhibitor Biomarkers Testing Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PARP Inhibitor Biomarkers Testing Product Market Competition by Manufacturers
2.1 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global PARP Inhibitor Biomarkers Testing Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PARP Inhibitor Biomarkers Testing Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Product Type & Application
2.7 Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Date of Enter into This Industry
2.8 Global PARP Inhibitor Biomarkers Testing Product Market Competitive Situation and Trends
2.8.1 Global PARP Inhibitor Biomarkers Testing Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PARP Inhibitor Biomarkers Testing Product Players Market Share by Revenue
2.8.3 Global PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PARP Inhibitor Biomarkers Testing Product Market Scenario by Region
3.1 Global PARP Inhibitor Biomarkers Testing Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Region: 2020-2031
3.2.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Region: 2020-2025
3.2.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Region: 2026-2031
3.3 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2020-2031
3.3.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2020-2025
3.3.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2026-2031
3.4 North America PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.4.1 North America PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2031)
3.4.3 North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.5.1 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2031)
3.5.3 Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Region
3.6.1 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2020-2031)
3.6.3 Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.7.1 Latin America PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2031)
3.7.3 Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.8.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2020-2031)
4.1.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2020-2025)
4.1.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2026-2031)
4.1.3 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2020-2031)
4.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2020-2031)
4.2.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2020-2025)
4.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2026-2031)
4.2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2020-2031)
4.3 Global PARP Inhibitor Biomarkers Testing Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2020-2031)
5.1.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2020-2025)
5.1.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2026-2031)
5.1.3 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2020-2031)
5.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2020-2031)
5.2.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2020-2025)
5.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2026-2031)
5.2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2020-2031)
5.3 Global PARP Inhibitor Biomarkers Testing Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Myriad Genetics, Inc.
6.1.1 Myriad Genetics, Inc. Company Information
6.1.2 Myriad Genetics, Inc. Description and Business Overview
6.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.1.5 Myriad Genetics, Inc. Recent Developments/Updates
6.2 Hoffmann-La Roche AG
6.2.1 Hoffmann-La Roche AG Company Information
6.2.2 Hoffmann-La Roche AG Description and Business Overview
6.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.2.5 Hoffmann-La Roche AG Recent Developments/Updates
6.3 Invitae Corporation
6.3.1 Invitae Corporation Company Information
6.3.2 Invitae Corporation Description and Business Overview
6.3.3 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.3.5 Invitae Corporation Recent Developments/Updates
6.4 NeoGenomics Laboratories, Inc.
6.4.1 NeoGenomics Laboratories, Inc. Company Information
6.4.2 NeoGenomics Laboratories, Inc. Description and Business Overview
6.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.4.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates
6.5 BPS Bioscience, Inc.
6.5.1 BPS Bioscience, Inc. Company Information
6.5.2 BPS Bioscience, Inc. Description and Business Overview
6.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.5.5 BPS Bioscience, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PARP Inhibitor Biomarkers Testing Product Industry Chain Analysis
7.2 PARP Inhibitor Biomarkers Testing Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PARP Inhibitor Biomarkers Testing Product Production Mode & Process Analysis
7.4 PARP Inhibitor Biomarkers Testing Product Sales and Marketing
7.4.1 PARP Inhibitor Biomarkers Testing Product Sales Channels
7.4.2 PARP Inhibitor Biomarkers Testing Product Distributors
7.5 PARP Inhibitor Biomarkers Testing Product Customer Analysis
8 PARP Inhibitor Biomarkers Testing Product Market Dynamics
8.1 PARP Inhibitor Biomarkers Testing Product Industry Trends
8.2 PARP Inhibitor Biomarkers Testing Product Market Drivers
8.3 PARP Inhibitor Biomarkers Testing Product Market Challenges
8.4 PARP Inhibitor Biomarkers Testing Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Myriad Genetics Inc
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories Inc.
BPS Bioscience, Inc.
List of Tables
 Table 1. Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global PARP Inhibitor Biomarkers Testing Product Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global PARP Inhibitor Biomarkers Testing Product Market Competitive Situation by Manufacturers in 2024
 Table 4. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market PARP Inhibitor Biomarkers Testing Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of PARP Inhibitor Biomarkers Testing Product, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Product Type & Application
 Table 12. Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global PARP Inhibitor Biomarkers Testing Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Testing Product as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global PARP Inhibitor Biomarkers Testing Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2020-2025) & (K Units)
 Table 18. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2020-2025)
 Table 19. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2026-2031) & (K Units)
 Table 20. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2026-2031)
 Table 21. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2020-2025)
 Table 23. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2026-2031)
 Table 25. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2025) & (K Units)
 Table 27. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2026-2031) & (K Units)
 Table 28. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2025) & (K Units)
 Table 32. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2026-2031) & (K Units)
 Table 33. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Type (2020-2025)
 Table 51. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Type (2026-2031)
 Table 52. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2020-2025)
 Table 53. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2026-2031)
 Table 54. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2020-2025)
 Table 57. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2026-2031)
 Table 58. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Type (2020-2025)
 Table 59. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Type (2026-2031)
 Table 60. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2020-2025)
 Table 61. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2026-2031)
 Table 62. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2020-2025)
 Table 63. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2026-2031)
 Table 64. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2020-2025)
 Table 67. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2026-2031)
 Table 68. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Application (2020-2025)
 Table 69. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Application (2026-2031)
 Table 70. Myriad Genetics, Inc. Company Information
 Table 71. Myriad Genetics, Inc. Description and Business Overview
 Table 72. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product
 Table 74. Myriad Genetics, Inc. Recent Developments/Updates
 Table 75. Hoffmann-La Roche AG Company Information
 Table 76. Hoffmann-La Roche AG Description and Business Overview
 Table 77. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product
 Table 79. Hoffmann-La Roche AG Recent Developments/Updates
 Table 80. Invitae Corporation Company Information
 Table 81. Invitae Corporation Description and Business Overview
 Table 82. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product
 Table 84. Invitae Corporation Recent Developments/Updates
 Table 85. NeoGenomics Laboratories, Inc. Company Information
 Table 86. NeoGenomics Laboratories, Inc. Description and Business Overview
 Table 87. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product
 Table 89. NeoGenomics Laboratories, Inc. Recent Developments/Updates
 Table 90. BPS Bioscience, Inc. Company Information
 Table 91. BPS Bioscience, Inc. Description and Business Overview
 Table 92. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product
 Table 94. BPS Bioscience, Inc. Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. PARP Inhibitor Biomarkers Testing Product Distributors List
 Table 98. PARP Inhibitor Biomarkers Testing Product Customers List
 Table 99. PARP Inhibitor Biomarkers Testing Product Market Trends
 Table 100. PARP Inhibitor Biomarkers Testing Product Market Drivers
 Table 101. PARP Inhibitor Biomarkers Testing Product Market Challenges
 Table 102. PARP Inhibitor Biomarkers Testing Product Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of PARP Inhibitor Biomarkers Testing Product
 Figure 2. Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PARP Inhibitor Biomarkers Testing Product Market Share by Type: 2024 & 2031
 Figure 4. Testing Kits Product Picture
 Figure 5. Testing Assays Product Picture
 Figure 6. Global PARP Inhibitor Biomarkers Testing Product Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global PARP Inhibitor Biomarkers Testing Product Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global PARP Inhibitor Biomarkers Testing Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global PARP Inhibitor Biomarkers Testing Product Market Size (2020-2031) & (US$ Million)
 Figure 13. Global PARP Inhibitor Biomarkers Testing Product Sales (2020-2031) & (K Units)
 Figure 14. Global PARP Inhibitor Biomarkers Testing Product Average Price (US$/Unit) & (2020-2031)
 Figure 15. PARP Inhibitor Biomarkers Testing Product Report Years Considered
 Figure 16. PARP Inhibitor Biomarkers Testing Product Sales Share by Manufacturers in 2024
 Figure 17. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest PARP Inhibitor Biomarkers Testing Product Players: Market Share by Revenue in PARP Inhibitor Biomarkers Testing Product in 2024
 Figure 19. PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global PARP Inhibitor Biomarkers Testing Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2020-2031)
 Figure 22. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2020-2031)
 Figure 26. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2020-2031)
 Figure 27. Germany PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2020-2031)
 Figure 34. China PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2020-2031)
 Figure 45. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of PARP Inhibitor Biomarkers Testing Product by Type (2020-2031)
 Figure 55. Global Revenue Market Share of PARP Inhibitor Biomarkers Testing Product by Type (2020-2031)
 Figure 56. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of PARP Inhibitor Biomarkers Testing Product by Application (2020-2031)
 Figure 58. Global Revenue Market Share of PARP Inhibitor Biomarkers Testing Product by Application (2020-2031)
 Figure 59. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Application (2020-2031)
 Figure 60. PARP Inhibitor Biomarkers Testing Product Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global PARP Inhibitor Biomarkers Service Market Research Report 2024
Global PARP Inhibitors for Breast Cancer Market Research Report 2024
Global Poly ADP Ribose Polymerase PARP Inhibitors Market Research Report 2024
DNA Repair PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PARP1 Antibody Market Research Report 2024
Global Enzyme Poly ADP Ribose Polymerase PARP Inhibitor Market Insights Forecast to 2030
Global Tumor Biomarker Test Market Research Report 2024
Global PARP Poly ADP ribose Polymerase Inhibitors Market Insights Forecast to 2030
Global Genomic Biomarkers Market Research Report 2024
Global Cardiac Biomarkers Testing Device Market Research Report 2025
Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Insights Forecast to 2030
Global PORCN Inhibitor Market Research Report 2024
Stool Biomarkers Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biological Safety Testing Product Market Research Report 2024
Global Infectious Disease Biomarker Testing Market Research Report 2024
Global Imaging Biomarker Market Research Report 2025
Global Specimen Validity Testing Products Market Research Report 2024
Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biological Sample Testing Market Research Report 2025
Global Biochemical Testing Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions